704 related articles for article (PubMed ID: 24315818)
21. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
22. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
[TBL] [Abstract][Full Text] [Related]
23. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
24. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
25. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
[TBL] [Abstract][Full Text] [Related]
26. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
28. Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/β-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7.
Yue X; Lan F; Xia T
Mol Ther; 2019 Nov; 27(11):1939-1949. PubMed ID: 31402274
[TBL] [Abstract][Full Text] [Related]
29. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
[TBL] [Abstract][Full Text] [Related]
30. miR-373-3p Targets DKK1 to Promote EMT-Induced Metastasis via the Wnt/
Weng J; Zhang H; Wang C; Liang J; Chen G; Li W; Tang H; Hou J
Biomed Res Int; 2017; 2017():6010926. PubMed ID: 28337453
[TBL] [Abstract][Full Text] [Related]
31. miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with β-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.
Li J; Yao L; Li G; Ma D; Sun C; Gao S; Zhang P; Gao F
PLoS One; 2015; 10(10):e0141168. PubMed ID: 26501139
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
Wang F; Li L; Chen Z; Zhu M; Gu Y
Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
[TBL] [Abstract][Full Text] [Related]
33. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.
Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C
Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218
[TBL] [Abstract][Full Text] [Related]
34. Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis.
Xu XD; He XJ; Tao HQ; Zhang W; Wang YY; Ye ZY; Zhao ZS
J Surg Oncol; 2013 Sep; 108(3):197-202. PubMed ID: 23832550
[TBL] [Abstract][Full Text] [Related]
35. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S
Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression.
Yuan H; Gao Y
Oncol Rep; 2015 Nov; 34(5):2706-14. PubMed ID: 26328886
[TBL] [Abstract][Full Text] [Related]
38. miR-27 promotes osteoblast differentiation by modulating Wnt signaling.
Wang T; Xu Z
Biochem Biophys Res Commun; 2010 Nov; 402(2):186-9. PubMed ID: 20708603
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-301a Promotes Cell Proliferation and Resistance to Apoptosis through PTEN/PI3K/Akt Signaling Pathway in Human Ovarian Cancer.
Ni J; Chen Y; Fei B; Zhu Y; Du Y; Liu L; Guo L; Zhu W
Gynecol Obstet Invest; 2021; 86(1-2):108-116. PubMed ID: 33596588
[TBL] [Abstract][Full Text] [Related]
40. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
